1. Home
  2. CXDO vs CRBU Comparison

CXDO vs CRBU Comparison

Compare CXDO & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$9.85

Market Cap

223.1M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$2.14

Market Cap

192.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXDO
CRBU
Founded
1995
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medicinal Chemicals and Botanical Products
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.1M
192.4M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
CXDO
CRBU
Price
$9.85
$2.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$9.20
$10.75
AVG Volume (30 Days)
353.6K
1.5M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
166.67
3.64
EPS
0.02
N/A
Revenue
$68,167,000.00
N/A
Revenue This Year
$45.26
$1.63
Revenue Next Year
$13.31
$10.93
P/E Ratio
$480.50
N/A
Revenue Growth
12.05
N/A
52 Week Low
$5.08
$0.92
52 Week High
$9.89
$3.53

Technical Indicators

Market Signals
Indicator
CXDO
CRBU
Relative Strength Index (RSI) 75.54 58.22
Support Level $6.04 $1.71
Resistance Level N/A $2.26
Average True Range (ATR) 0.61 0.13
MACD 0.17 0.01
Stochastic Oscillator 98.71 63.27

Price Performance

Historical Comparison
CXDO
CRBU

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: